(Q33502314)

English

FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

medical oncology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Bajetta E

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Di Bartolomeo M

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Carnaghi C

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Buzzoni R

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Mariani L

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Gebbia V

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Comella G

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Pinotti G

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Ianniello G

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Schieppati G

10

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Bochicchio AM

11

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Maiorino L

12

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

0 references

publication date

1 April 1998

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

77

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1149-1154

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1998.191

0 references

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150127

21 June 2018

Initial or delayed chemotherapy with best supportive care in advanced gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150127

21 June 2018

The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150127

21 June 2018

Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150127

21 June 2018

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150127

21 June 2018

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150127

21 June 2018

Role of chemotherapy in the palliation of gastrointestinal malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150127

21 June 2018

Optimal two-stage designs for phase II clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150127

21 June 2018

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150127

21 June 2018

Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150127

21 June 2018

Gastric cancer: chemotherapy of advanced disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150127

21 June 2018

Phase II Study of the Etoposide, Leucovorin and Fluorouracil Combination for Patients with Advanced Gastric Cancer Unsuitable for Aggressive Chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9569054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9569054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9569054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II Trial of Etoposide (V), Adriamycin (A), and Cisplatinum (P) in Patients with Metastatic Gastric Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9569054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction chemotherapy with and without recombinant human granulocyte colony-stimulating factor support in locally advanced stage IIIA/B non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9569054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing the dose intensity of chemotherapy by means of granulocyte-colony stimulating factor (G-CSF) support in the treatment of small cell lung cancer (SCLC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/9569054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction

1 reference

https://pubmed.ncbi.nlm.nih.gov/9569054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9569054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer in the European community and its member states

1 reference

https://pubmed.ncbi.nlm.nih.gov/9569054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemotherapy with autologous bone marrow transplantation in the treatment of advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9569054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confidence limits for probability of response in multistage phase II clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/9569054

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1998.191

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33502314&oldid=1585839771"